HLA
Hamilton Lane Advisors’s 10x Genomics TXG Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,718
| Closed | -$600K | – | 26 |
|
|
2023
Q4 | $600K | Buy |
+10,718
| New | +$600K | 0.25% | 22 |
|
|
2023
Q3 | – | Sell |
-18,731
| Closed | -$1.05M | – | 48 |
|
|
2023
Q2 | $1.05M | Buy |
18,731
+10,988
| +142% | +$614K | 0.46% | 32 |
|
|
2023
Q1 | $432K | Sell |
7,743
-18,667
| -71% | -$1.04M | 0.14% | 45 |
|
|
2022
Q4 | $962K | Buy |
26,410
+18,667
| +241% | +$680K | 0.35% | 32 |
|
|
2022
Q3 | $221K | Hold |
7,743
| – | – | 0.08% | 57 |
|
|
2022
Q2 | $350K | Hold |
7,743
| – | – | 0.14% | 53 |
|
|
2022
Q1 | $589K | Hold |
7,743
| – | – | 0.13% | 51 |
|
|
2021
Q4 | $1.15M | Hold |
7,743
| – | – | 0.15% | 52 |
|
|
2021
Q3 | $1.13M | Sell |
7,743
-14,521
| -65% | -$2.11M | 0.19% | 50 |
|
|
2021
Q2 | $4.36M | Buy |
22,264
+1,313
| +6% | +$257K | 1.36% | 18 |
|
|
2021
Q1 | $3.79M | Sell |
20,951
-54,580
| -72% | -$9.88M | 1.24% | 19 |
|
|
2020
Q4 | $10.7M | Buy |
75,531
+38,444
| +104% | +$5.44M | 3.99% | 6 |
|
|
2020
Q3 | $4.62M | Buy |
37,087
+32,290
| +673% | +$4.03M | 2.24% | 8 |
|
|
2020
Q2 | $428K | Buy |
+4,797
| New | +$428K | 0.23% | 32 |
|